Abstract
Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been used in the treatment of malignant disease for over 20 years and for the treatment of bladder cancer since 1976. Major complications of this treatment are infrequent. We report two cases of systemic illness with pulmonary manifestations after treatment with intravesical BCG.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brosman S. A. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma. J Urol. 1982 Jul;128(1):27–30. doi: 10.1016/s0022-5347(17)52736-6. [DOI] [PubMed] [Google Scholar]
- Israel-Biet D., Venet A., Sandron D., Ziza J. M., Chretien J. Pulmonary complications of intravesical Bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis. 1987 Mar;135(3):763–765. doi: 10.1164/arrd.1987.135.3.763. [DOI] [PubMed] [Google Scholar]
- Lamm D. L. Bacillus Calmette-Guerin immunotherapy for bladder cancer. J Urol. 1985 Jul;134(1):40–47. doi: 10.1016/s0022-5347(17)46972-2. [DOI] [PubMed] [Google Scholar]
- Lamm D. L., Stogdill V. D., Stogdill B. J., Crispen R. G. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol. 1986 Feb;135(2):272–274. doi: 10.1016/s0022-5347(17)45606-0. [DOI] [PubMed] [Google Scholar]
- Morales A., Eidinger D., Bruce A. W. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976 Aug;116(2):180–183. doi: 10.1016/s0022-5347(17)58737-6. [DOI] [PubMed] [Google Scholar]
- Steg A., Sicard D., Leleu C., Debré B., Boccon-Gibod L. Systemic complications of intravesical BCG therapy for bladder cancer. Lancet. 1985 Oct 19;2(8460):899–899. doi: 10.1016/s0140-6736(85)90169-2. [DOI] [PubMed] [Google Scholar]